![Zorbtive [somatropin (rDNA origin) for injection]](images/Zorbtive_180.png)
How SeroCareSM
can help Zorbtive patients
Helpful information for people with SBS considering Zorbtive treatment
Clinical information about Zorbtive for health professionals
Clinical opinions about Zorbtive and goals of treatment for Short Bowel Syndrome
If you have been diagnosed with Short Bowel Syndrome, Zorbtive® [somatropin (rDNA origin) for injection] treatment has the potential to reduce your need for parenteral nutrition.
The Zorbtive
The Zorbtive Patient
The Zorbtive
|
You may enjoy an improved lifestyle after treatment.
Please read “Understanding Zorbtive Treatment,” our patient handbook, and the Zorbtive Patient Information Leaflet.
This information may help you and your doctor decide whether treatment is right for you. You will:
- Learn about people with SBS who were treated with Zorbtive
- Get answers to some Frequently Asked Questions about treatment
- Find out about the special oral diet, and
- Find out about possible side effects of treatment
This information may be read on your computer or printed.
Click on the images at right or the underlined text above.
How SeroCareSM can help
Zorbtive patients
Helpful information for people with SBS, considering
Zorbtive treatment
Clinical information about Zorbtive for health
professionals
Clinical opinions about Zorbtive and goals
of treatment for Short Bowel Syndrome
Glossary
Links
Home
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed.
Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling).
Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or
other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure
in the brain. Make sure and talk with your doctor about these side effects.
Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications.
This information is not intended to replace discussions with your healthcare professional.
For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet
and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCareSM
toll free at 800-714-2437. Zorbtive is available by prescription only.
This Web site was developed by EMD
Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS
patients
and interested healthcare professionals about this treatment for Short Bowel
Syndrome. Zorbtive is exclusively marketed by
Emmaus Medical, Inc. (emmausmedical.com),
Tel: 1-877-420-6493.
This site contains medical information that is intended for residents of the United States
only and is not meant to substitute for the advice provided by a medical professional.
Always consult a doctor if you have health concerns. Use and access of this
site is subject to the terms and conditions as set out in our Legal Statement
and Privacy Policy.
© 2007 EMD Serono, Inc. All rights reserved. 